Nuvectis Pharma to Present at the H.C. Wainwright 26th Annual Global Investment Conference
Fort Lee, NJ, Sept. 05, 2024 (GLOBE NEWSWIRE) -- Nuvectis Pharma, Inc. (NASDAQ: NVCT) ("Nuvectis" or the "Company"), a clinical-stage...
Pharmaceutical
Palisade Bio Reports Data Demonstrating PDE4B Expression in Patient Cohorts Could be Utilized as a Potential Marker for Patient Stratification
Curated data show expression of PDE4B above a specific measurable threshold observed in 70% of adult colitis patients and 90%...
Arcutis Completes Enrollment of Phase 1b Alopecia Areata Study Evaluating ARQ-255
ARQ-255 is a topical Janus kinase 1 (JAK1) inhibitor suspension formulated as a potential topical treatment for alopecia areataProprietary Deep...
Ocuphire Pharma Initiates VEGA-3 Phase 3 Trial Evaluating Phentolamine Ophthalmic Solution 0.75% for Presbyopia
Top-line data from VEGA-3 Phase 3 trial expected in first half of 2025 Top-line data from LYNX-2 Phase 3 trial...
Ardelyx to Participate at the 2024 Cantor Global Healthcare Conference
WALTHAM, Mass., Sept. 05, 2024 (GLOBE NEWSWIRE) -- Ardelyx, Inc. (Nasdaq: ARDX), a biopharmaceutical company founded with a mission to...
Eccogene Appoints Glenn Reicin as Chief Financial Officer
BOSTON, Mass. and SHANGHAI, Sept. 05, 2024 (GLOBE NEWSWIRE) -- Eccogene, a clinical-stage biopharmaceutical company developing next-generation oral small molecule...
Exyte acquires TTP Group to accelerate growth of Biopharma and Life Sciences business
TTP Group is a leading engineering firm specializing in biotech and pharmaceutical industryThe company serves blue-chip clients in Europe TTP Group...
IKA introduces new accessories for HABITAT research bioreactor
More options for smoother bioprocessing workflows and greater data reliability STAUFEN, Germany, Sept. 5, 2024 /PRNewswire/ -- IKA, a global company in...
Breakthrough Therapy designation for Sanbexin sublingual tablets granted by the United States Food and Drug Administration
NANJING, China, Sept. 5, 2024 /PRNewswire/ -- On September 2, 2024, Simcere Pharmaceuticals Group Ltd. (2096.HK) announced that Sanbexin Sublingual Tablets...
Ginkgo Regains Compliance with NYSE Minimum Bid Price Requirement
BOSTON, Sept. 4, 2024 /PRNewswire/ -- Ginkgo Bioworks Holdings, Inc. (NYSE: DNA, "Ginkgo" or the "Company"), which is building the...
International Isotopes Inc. and Phantech Medical Launch PhanQual to Revolutionize Calibration Sources for Pre-Clinical Imaging
IDAHO FALLS, Idaho and MADISON, Wis., Sept. 4, 2024 /PRNewswire/ -- International Isotopes, Inc. (INIS) and Phantech Medical (Phantech) have entered...
Sanguine Biosciences Prioritizes Excellence, Information Security, and Privacy with ISO Certifications
WOBURN, Mass., Sept. 4, 2024 /PRNewswire/ -- Sanguine Biosciences, a leading biospecimen procurement company focused on personalized medicine and biomedical research,...
Signant Health expands availability of its eClinical solutions by joining IQVIA One Home for Sites initiative
PHILADELPHIA, Sept. 4, 2024 /PRNewswire/ -- Signant Health, the leader in evidence generation for modern clinical trials, announced today it...
CORUNDUM SYSTEMS BIOLOGY APPOINTS JESSICA SCHNEIDER AS CHIEF SCIENTIFIC OFFICER
Former Takeda Ventures Director Joins Investment Company to Spur Systems Biology Business Creation and Innovation TOKYO, Sept. 4, 2024 /PRNewswire/...
Pharma Targeting celebrates a year of growth and milestones amid industry challenges
Customised consultancy and revolutionary 3 Step Model brings global growth for company and its booming client base LONDON, Sept. 4,...
Phesi Receives Frost & Sullivan’s Global Enabling Technology Leadership Award for Revolutionizing Clinical Development with Its Trial Accelerator Platform
Phesi's Trial Accelerator™ Platform empowers trial sponsors to make informed decisions swiftly, expediting drug development timelines while upholding the highest...
Royal Society Hosts BioAro’s UK Launch in Partnership with Golden Helix Foundation to Enhance Genomic Medicine Education
NEW YORK, Sept. 4, 2024 /PRNewswire/ -- BioAro successfully launched its presence in the UK at the Royal Society on August 29th,...
Constantiam Biosciences Secures $2.05M Phase II SBIR Grant from NHGRI to Advance Functional Analysis Platform for Variants of Uncertain Significance (VUS)
HOUSTON, Sept. 4, 2024 /PRNewswire/ -- Constantiam Biosciences, a startup focused on powering genomic medicine, is pleased to announce that...
HealthVerity introduces taXOnomy℠, the nation’s most comprehensive closed (X) and open (O) claims dataset for pharmaceutical research
PHILADELPHIA, Sept. 4, 2024 /PRNewswire/ -- HealthVerity, the leader in synchronizing transformational technologies and real-world data (RWD) to advance the...
Emmes awarded multi-task, IDIQ contract with $50M ceiling, to support NIDA’s clinical trials network
Emmes, part of Emmes Group, today announced they will provide a Clinical Coordinating Center for the NIH's National Institute on...